Literature DB >> 19252508

Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population.

Emin Ozbek1, Ali I Tasci, Volkan Tugcu, Yusuf O Ilbey, Abdulmuttalip Simsek, Levent Ozcan, Emre C Polat, Vedat Koksal.   

Abstract

We evaluated the genotypes of the serotonin transporter gene (5-HTT) in patients with premature ejaculation (PE) to determine the role of genetic factors in the etiopathogenesis of PE and possibly to identify the patient subgroups. A total of 70 PE patients and 70 controls were included in this study. All men were heterosexual, had no other disorders and were either married or in a stable relationship. PE was defined as ejaculation that occurred within 1 min of vaginal intromission. Genomic DNA from patients and controls was analyzed using polymerase chain reaction, and allelic variations of the promoter region of the serotonin transporter gene (5-HTTLPR) were determined. The 5-HTTLPR (serotonin transporter promoter gene) genotypes in PE patients vs. controls were distributed as follows: L/L 16% vs. 17%, L/S 30% vs. 53% and S/S 54% vs. 28%. We examined the haplotype analysis for three polymorphisms of the 5-HTTLPR gene: LL, LS and SS. The appropriateness of the allele frequencies in the 5-HTTLPR gene was analyzed by the Hardy-Weinberg equilibrium using the chi2-test. The short (S) allele of the 5-HTTLPR gene was significantly more frequent in PE patients than in controls (P<0.05). We suggest that the 5-HTTLPR gene plays a role in the pathophysiology of all primary PE cases. Further studies are needed to evaluate the relationship between 5-HTTLPR gene polymorphism and patient subgroup (such as primary and secondary PE) responses to selective serotonin reuptake inhibitors as well as ethnic differences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252508      PMCID: PMC3735292          DOI: 10.1038/aja.2008.3

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  21 in total

Review 1.  Premature ejaculation: current and future treatments.

Authors:  Levent Gurkan; Matthew Oommen; Wayne J G Hellstrom
Journal:  Asian J Androl       Date:  2008-01       Impact factor: 3.285

2.  Familial occurrence of primary premature ejaculation.

Authors:  M D Waldinger; M Rietschel; M M Nöthen; M W Hengeveld; B Olivier
Journal:  Psychiatr Genet       Date:  1998       Impact factor: 2.458

3.  A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

Authors:  A Heinz; D W Jones; C Mazzanti; D Goldman; P Ragan; D Hommer; M Linnoila; D R Weinberger
Journal:  Biol Psychiatry       Date:  2000-04-01       Impact factor: 13.382

Review 4.  Emerging drugs for premature ejaculation.

Authors:  Marcel D Waldinger
Journal:  Expert Opin Emerg Drugs       Date:  2006-03       Impact factor: 4.191

5.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

6.  Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.

Authors:  K Y Little; D P McLaughlin; L Zhang; P R McFinton; G W Dalack; E H Cook; B J Cassin; S J Watson
Journal:  Arch Gen Psychiatry       Date:  1998-09

7.  Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.

Authors:  M D Waldinger; M W Hengeveld; A H Zwinderman
Journal:  Br J Urol       Date:  1997-04

8.  Sertraline treatment for premature ejaculation.

Authors:  J Mendels; A Camera; C Sikes
Journal:  J Clin Psychopharmacol       Date:  1995-10       Impact factor: 3.153

9.  Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.

Authors:  M D Waldinger; M W Hengeveld; A H Zwinderman; B Olivier
Journal:  J Clin Psychopharmacol       Date:  1998-08       Impact factor: 3.153

10.  Allelic variation of human serotonin transporter gene expression.

Authors:  A Heils; A Teufel; S Petri; G Stöber; P Riederer; D Bengel; K P Lesch
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372

View more
  23 in total

Review 1.  Advances in understanding and treating premature ejaculation.

Authors:  Theodore R Saitz; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2015-10-27       Impact factor: 14.432

2.  Hardy Weinberg equilibrium in genetic PE research remains critical to avoid misinterpretation.

Authors:  Marcel D Waldinger; Paddy K C Janssen; Dave H Schweitzer
Journal:  Asian J Androl       Date:  2009-05-25       Impact factor: 3.285

3.  Temperament and Character Differences in Patients with Premature Ejaculation.

Authors:  Bülent Altunoluk; Erman BAğCIOĞLU; Erkan Efe; Bülent Bahçeci; Haluk Söylemez
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

4.  Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology.

Authors:  Marcel D Waldinger
Journal:  Korean J Urol       Date:  2011-01-24

5.  Study of the link between dopamine transporter gene polymorphisms and response to paroxetin and escitalopram in patients with lifelong premature ejaculation.

Authors:  T K Eltonsi; T M Tawfik; L A Rashed; S F GamalEl Din; M A Mahmoud
Journal:  Int J Impot Res       Date:  2017-09-14       Impact factor: 2.896

6.  Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism.

Authors:  A M Salem; I I Kamel; L A Rashed; S F GamalEl Din
Journal:  Int J Impot Res       Date:  2016-09-29       Impact factor: 2.896

7.  Sympathetic skin response in patients with primary premature ejaculation.

Authors:  J-D Xia; Y-F Han; L-H Zhou; Z-P Xu; Y Chen; Y-T Dai
Journal:  Int J Impot Res       Date:  2013-05-02       Impact factor: 2.896

8.  Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

Authors:  Jana Strohmaier; Stefan Wüst; Rudolf Uher; Neven Henigsberg; Ole Mors; Joanna Hauser; Daniel Souery; Astrid Zobel; Mojca Z Dernovsek; Fabian Streit; Christine Schmäl; Dejan Kozel; Anna Placentino; Anne Farmer; Peter McGuffin; Katherine J Aitchison; Marcella Rietschel
Journal:  World J Biol Psychiatry       Date:  2011-03-09       Impact factor: 4.132

Review 9.  Drosophila Corazonin Neurons as a Hub for Regulating Growth, Stress Responses, Ethanol-Related Behaviors, Copulation Persistence and Sexually Dimorphic Reward Pathways.

Authors:  Ziam Khan; Maya Tondravi; Ryan Oliver; Fernando J Vonhoff
Journal:  J Dev Biol       Date:  2021-07-05

10.  A meta-analysis of the effects of the 5-hydroxytryptamine transporter gene-linked promoter region polymorphism on susceptibility to lifelong premature ejaculation.

Authors:  Lijie Zhu; Yuanyuan Mi; Xiaoming You; Sheng Wu; Hongbao Shao; Feng Dai; Tao Peng; Feng Qin; Ninghan Feng
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.